Search Result "spironolactone treatment"
Long-Lasting Effects of Spironolactone after its Withdrawal in Patientswith Hyperandrogenic Skin Disorders
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 23 Issue: 2 Year: 2023 Page: 188-195
Author(s):
Marinobufagenin in Urine: A Potential Marker of Predisposition to Ethanol and a Target for Spironolactone
Journal: Current Hypertension Reviews
Volume: 14 Issue: 1 Year: 2018 Page: 35-38
Author(s): Vladimir A. Kashkin,Elena V. Shekunova,Alexei Y. Egorov,Alexei Y. Bagrov
The Impact of Spironolactone Co-administration on Cyclosporin Initial DosageOptimization for Pediatric Refractory Nephrotic Syndrome
Journal: Current Pharmaceutical Design
Volume: 30 Issue: 18 Year: 2024 Page: 1419-1432
Author(s):
Captopril and Spironolactone can Attenuate Diabetic Nephropathy in Wistar Ratsby Targeting ABCA1 and microRNA-33
Journal: Current Pharmaceutical Design
Volume: 28 Issue: 16 Year: 2022 Page: 1367-1372
Author(s):
Do Pleiotropic Effects of Spironolactone in Women with PCOS Make it More thanan Anti-androgen? Evidence from a Systematic Review and Meta-analysis
Journal: Current Pharmaceutical Design
Volume: 29 Issue: 19 Year: 2023 Page: 1486-1496
Author(s): Mir Mahmood Asrar,Idrees Ayoub Shah,Imtiyaz Ahmad Wani,Mohd. Ashraf Ganie
Advances in Heart Failure with Preserved Ejection Fraction Management -The Role of Sacubitril-Valsartan, Pirfenidone, Spironolactone and Empagliflozin:Is Success a Series of Small Victories?
Journal: Current Pharmaceutical Design
Volume: 29 Issue: 7 Year: 2023 Page: 502-508
Author(s): Vassilios P. Vassilikos
Medical Treatment of Hirsutism in Women
Journal: Current Medicinal Chemistry
Volume: 17 Issue: 2 Year: 2010 Page: 2530-2538
Author(s): F. Lumachi, S.M.M. Basso
Aldosterone Receptor Antagonists and Cardiovascular Disease: Do We Need a Change of the Guard?
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 4 Issue: 2 Year: 2006 Page: 129-153
Author(s): Coty W. Jewell, Linley E. Watson, Jonathan Mock, David E. Dostal
The Risks and Benefits of Therapy with Aldosterone Receptor Antagonist Therapy
Journal: Current Drug Safety
Volume: 2 Issue: 1 Year: 2007 Page: 71-77
Author(s): Domenic A. Sica
Finerenone: A Novel Drug Discovery for the Treatment of Chronic KidneyDisease
Journal: Current Drug Discovery Technologies
Volume: 21 Issue: 6 Year: 2024 Page: 75-83
Author(s): Jagdish K. Sahu